←back to thread

996

(lucumr.pocoo.org)
1001 points genericlemon24 | 1 comments | 06 Sep 25 13:20 UTC | HN request time: 0s | source
Show context
whstl ◴[06 Sep 25 15:55 UTC] No.45150377[source]▶
996 is just theater for investors.

Saw this happening even at YC companies. There was always that stupid expectation of overworking, staying until 9.

The reality is that people twiddle thumbs.

And the disorganization and micromanagement power plays are enough to negate any additional worked hour.

This ranges from pure disorganization in terms of what to build to having 3 hour meetings with the whole fucking company where the CEO pretends they have something worthwhile to say for 3 hours.

replies(7): >>45150486 #>>45150598 #>>45151036 #>>45151363 #>>45152453 #>>45152726 #>>45152828 #
graemep ◴[06 Sep 25 16:07 UTC] No.45150486[source]▶
> 996 is just theater for investors.

Investors who have not heard of the research into productivity that says long hours have no significant benefit for skilled work? Who have not heard of diminishing returns? Who have no experience of the reality of working long hours themselves?

replies(13): >>45150563 #>>45150600 #>>45150615 #>>45150675 #>>45150690 #>>45150754 #>>45150788 #>>45150973 #>>45150983 #>>45151780 #>>45151908 #>>45151986 #>>45152349 #
throwawaybob420 ◴[06 Sep 25 16:30 UTC] No.45150675[source]▶
Investors are dipshits more often than not. Just because someone has money to throw doesn’t mean they know much about many things.
replies(1): >>45150783 #
graemep ◴[06 Sep 25 16:41 UTC] No.45150783[source]▶
They also have to be stupid enough not to hire someone why does know things to manage their money for them.
replies(1): >>45152814 #
1. rsynnott ◴[06 Sep 25 21:04 UTC] No.45152814{3}[source]▶
See the story of Theranos. Pretty much everyone who did basic due diligence declined to invest in Theranos; they apparently didn’t even have faked audited accounts for the purpose. But there were enough dumb rich people willing either not to ask the person who knew, or to ignore them, that Theranos had no trouble getting funding.

Now the average VC fund isn’t _as_ incompetent as the average Theranos investor, but it’s still a field where decisions by ‘visionaries’ are often valued over expertise.